Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Feb;347(2):180-5.
doi: 10.1007/BF00169264.

Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex

Affiliations
Comparative Study

Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex

M C Michel et al. Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb.

Abstract

We have studied the role of alpha 1A- and alpha 1B-adrenoceptors in noradrenaline- and methoxamine-stimulated inositol phosphate accumulation in rat renal cortical slices. [3H]Prazosin binding studies with and without inactivation of alpha 1B-adrenoceptors by chloroethylclonidine treatment suggested that noradrenaline lacks relevant selectivity for alpha 1-adrenoceptor subtypes. Both agonists stimulated [3H]inositol phosphate accumulation with similar maximal effects. The alpha 1A-selective antagonists 5-methyl-urapidil and (+)-niguldipine inhibited inositol phosphate formation by both agonists with shallow biphasic curves but the high affinity component was only 15%-31% and 38%-41%, respectively. The irreversible alpha 1B-selective antagonist chloroethylclonidine inhibited inositol phosphate generation by both agonists by 54%-57%. In contrast to our previous data in rat cerebral cortical slices, we conclude that in rat renal cortex both alpha 1A- and alpha 1B-adrenoceptors are involved in noradrenaline- and methoxamine-stimulated inositol phosphate generation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Pharmacol. 1991 Oct;40(4):531-8 - PubMed
    1. Br J Pharmacol. 1990 May;100(1):3-4 - PubMed
    1. Pharmacol Rev. 1988 Jun;40(2):87-119 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):385-7 - PubMed
    1. Mol Pharmacol. 1989 Mar;35(3):324-30 - PubMed

Publication types